Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001185185-25-001508
Filing Date
2025-10-21
Accepted
2025-10-21 08:50:47
Documents
1
Period of Report
2025-10-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3964
  Complete submission text file 0001185185-25-001508.txt   5406
Mailing Address 10224 FALLS ROAD POTOMAC MD 20854
Business Address 10224 FALLS ROAD POTOMAC MD 20854 301-529-4996
IGC Pharma, Inc. (Issuer) CIK: 0001326205 (see all company filings)

EIN.: 202760393 | State of Incorp.: MD | Fiscal Year End: 0331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 914 SPRING HILL ROAD MCLEAN VA 22102
Business Address
Moran James P (Reporting) CIK: 0001907094 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32830 | Film No.: 251405441